openPR Logo
Press release

Kingdom of Saudi Arabia Healthcare Market to Reach $152.6 Billion by 2034 as Vision 2030 Privatization and Digital Health Transformation Reshape Medical Services

05-12-2026 02:21 PM CET | Health & Medicine

Press release from: Dimension Market Research

Kingdom of Saudi Arabia (KSA) Healthcare Market  Size, Share, Trends & Outlook Report 2034

Kingdom of Saudi Arabia (KSA) Healthcare Market Size, Share, Trends & Outlook Report 2034

The Kingdom of Saudi Arabia (KSA) Healthcare Market is poised for substantial growth, with market valuation projected to rise from an estimated USD 68.3 billion in 2025 to USD 152.6 billion by 2034, registering a strong compound annual growth rate (CAGR) of 9.3%. According to Dimension Market Research, this expansion is being driven by four converging forces: rapid population growth and urbanization, the rising burden of chronic diseases including diabetes and cardiovascular conditions, the transformative impact of Vision 2030 healthcare privatization initiatives, and the accelerating adoption of digital health technologies including telemedicine, AI, and robotics.

Healthcare in Saudi Arabia-encompassing prevention, diagnosis, treatment, rehabilitation, and palliative care-has become a strategic priority for the Kingdom as it diversifies its economy beyond oil revenues. According to Dimension Market Research, the healthcare market is primarily government-funded, offering citizens free or subsidized care, with increasing private sector participation through public-private partnerships (PPPs). With Saudi Arabia's population surpassing 35 million and a large segment being young adults, demand for both primary and specialized healthcare services continues to rise. The Kingdom's focus on healthcare quality through Vision 2030 is expanding healthcare access and improving service delivery across all regions.

📄 Get Your Sample Report Today → https://dimensionmarketresearch.com/request-sample/kingdom-of-saudi-arabia-healthcare-market/

🔷 The News Angle: From Oil Dependency to Healthcare Hub-Saudi Arabia's Vision 2030 Transformation

The dominant narrative reshaping the KSA healthcare market is the fundamental transition from a government-funded, oil-dependent healthcare system to a diversified, privatized, technology-enabled ecosystem that positions Saudi Arabia as a regional leader in medical innovation and patient care.

Vision 2030 as accelerator is the most powerful catalyst. The Saudi government's Vision 2030 initiative focuses on diversifying the economy and improving public services, with a major focus on healthcare. Through increased privatization and public-private partnerships (PPPs), the Kingdom is modernizing its healthcare infrastructure, improving efficiency, and expanding access to high-quality care while reducing government spending on healthcare services. In October 2024, Saudi Arabia's Minister of Health announced investment deals worth more than USD 13.3 billion to boost the healthcare sector, including agreements with NUPCO, Novo Nordisk, Sanofi for pharmaceutical manufacturing, Fakeeh Care Group for expansion, and Almoosa Health Group to create new care centers and hospitals.

Chronic disease burden is equally transformative. Lifestyle-related diseases including diabetes, heart disease, and obesity are on the rise, creating greater demand for specialized care and preventive health services. As the population ages, there is major demand for healthcare services related to geriatrics and the management of chronic diseases like diabetes, hypertension, and cardiovascular conditions, driving investments in specialized care facilities, rehabilitation services, and long-term healthcare solutions. The Kingdom is implementing comprehensive chronic disease management systems to monitor patients, provide personalized care, and prevent complications.

Digital health and medical innovation represents the third pillar. Saudi Arabia is increasingly integrating artificial intelligence and robotics in healthcare for diagnostics, surgery, and patient care management. AI-powered tools are being used to ease administrative tasks, improve decision-making in clinical settings, and enhance patient outcomes. The government has invested in telemedicine platforms to enhance healthcare access, mainly in rural areas, allowing patients to consult healthcare professionals remotely. The Ministry of Health launched the "Regulatory Healthcare Sandbox" program in August 2024, providing a secure platform for innovators to experiment and refine ideas-a major milestone in boosting investment and modernizing Saudi Arabia's healthcare system.

🔷 Key Insights: Data Points Defining the KSA Healthcare Transformation

Private Insurance Dominates Healthcare Insurance Segment: With government promoting privatization, private insurance helps cover treatments in private hospitals and clinics, providing faster, more specialized care; mandatory for non-citizens.

Hospitals & Clinics Lead Healthcare Services: Providing essential medical services to a growing population; vital to government's efforts to improve healthcare access and quality through technology and private investment.

Vaccines Lead Biotechnology Segment: Government focus on immunization programs, especially during COVID-19, increased vaccine demand; local production and international partnerships boost the biotechnology sector.

Prescription Drugs Lead Pharmaceuticals Segment: Increasing demand for treatments related to chronic diseases, infections, and other health conditions drives need for effective prescription medications.

Diagnostic Devices Lead Medical Devices Segment: Early detection and accurate diagnosis of diseases; imaging systems, blood analyzers, and point-of-care testing tools improve efficiency and precision.

Electronic Health Records Lead Healthcare IT: Enhancing efficiency and accuracy of medical data management; allowing providers to store, access, and share patient information for better care coordination.

Hospital Construction Leads Healthcare Infrastructure: Government investing heavily in advanced hospitals and healthcare facilities as part of Vision 2030 to increase bed capacity and introduce advanced medical technologies.

Private Insurance Dominates (Continued): Also supports growing expatriate population, as private insurance is mandatory for non-citizens; helps diversify funding sources, reducing pressure on government resources.

Population Growth: Saudi Arabia's population has surpassed 35 million, with a large segment being young adults, increasing demand for both primary and specialized healthcare services.

Public-Private Partnerships: Government promoting PPPs to expand healthcare infrastructure, build new hospitals, and enhance quality of care, leveraging private investment and expertise.

Medical Tourism Development: Saudi Arabia positioning itself as a hub for medical tourism with world-class healthcare facilities providing high-quality treatments in cardiology, orthopedics, and fertility.

Workforce Challenge: Heavy reliance on foreign medical professionals; shortage of local healthcare workers could impact service delivery as demand grows.

📄 Get the Insights You Need to Drive Real Impact → https://dimensionmarketresearch.com/request-sample/kingdom-of-saudi-arabia-healthcare-market/

🔷 Market Dynamics: Drivers, Restraints, and Strategic Opportunities

Drivers: Aging Population & Vision 2030 Privatization
The primary driver is the aging population and chronic disease burden. As the population ages, there is major demand for healthcare services related to geriatrics and the management of chronic diseases like diabetes, hypertension, and cardiovascular conditions, driving investments in specialized care facilities, rehabilitation services, and long-term healthcare solutions to meet evolving healthcare needs.

Simultaneously, Vision 2030 and healthcare privatization are driving market expansion. The Saudi government's Vision 2030 initiative focuses on diversifying the economy and improving public services, with a major focus on healthcare. Through increased privatization and public-private partnerships (PPPs), the Kingdom is modernizing its healthcare infrastructure, improving efficiency, and expanding access to high-quality care while reducing government spending on healthcare services. In October 2024, investment deals worth more than USD 13.3 billion were announced to boost the healthcare sector.

Restraints: Workforce Shortages & High Healthcare Costs
Despite momentum, significant barriers remain. Healthcare workforce shortages challenge the sector. Despite huge investments, Saudi Arabia experiences challenges in maintaining a skilled workforce, mainly in specialized fields like nursing, geriatrics, and mental health. The country depends highly on foreign medical professionals, and a shortage of local healthcare workers could impact delivery of high-quality services as demand grows.

Additionally, high healthcare costs remain a major restraint. While the government provides subsidized healthcare for citizens, the increase in the cost of medical treatments, advanced technologies, and pharmaceuticals creates financial burden on private healthcare providers and may lead to disparities in access, particularly in underserved regions or for non-citizen residents.

Opportunities: Medical Tourism Expansion & Digital Health Growth
Saudi Arabia has significant potential to become a leading medical tourism destination, with advanced healthcare facilities and world-class treatments available in areas such as orthopedics, cardiology, and fertility. The government's focus on improving healthcare infrastructure and promoting the sector presents an opportunity to attract international patients and boost the economy. The Kingdom is developing advanced hospitals and specialized centers offering treatments in cardiology, orthopedics, and cosmetic surgery, supported by Vision 2030.

The increasing demand for telemedicine, remote patient monitoring, and digital health platforms provides a valuable opportunity for technology companies to expand their presence in Saudi Arabia's healthcare market. With strong government support for e-health and innovation through initiatives like the Regulatory Healthcare Sandbox program, there is room for development of new solutions that enhance patient care and operational efficiency.

🔷 Selective Segmentation: Where the Growth is Concentrated

By Healthcare Services (Hospitals & Clinics-Leading Share): Hospitals and clinics are set to lead Saudi Arabia's healthcare market by providing essential medical services to a growing population. They offer numerous treatments from basic care to specialized procedures, meeting growing demand due to population growth and chronic disease increase. These institutions are vital to the government's efforts to improve healthcare access and quality, supported by technological advancement and private sector investments. Telehealth/Telemedicine is the fastest-growing service segment, transforming healthcare delivery by making medical services more accessible, mainly in remote areas, and supporting chronic disease management and mental health.

By Pharmaceuticals (Prescription Drugs-Leading Share): Prescription drugs are expected to be a leading segment, driving much growth in the healthcare market. With increasing demand for treatments related to chronic diseases, infections, and other health conditions, the need for effective prescription medications has risen. The Kingdom's growing healthcare infrastructure and focus on enhancing healthcare access further drive demand for high-quality prescription drugs. Biologics and Biosimilars are highly important and expected to grow significantly, providing advanced treatments for complex diseases like cancer, diabetes, and autoimmune disorders while reducing healthcare costs.

By Biotechnology (Vaccines-Leading Share): Vaccines are expected to have a significant impact on Saudi Arabia's healthcare market by preventing infectious diseases and enhancing public health. The government's focus on immunization programs, especially during global health challenges like COVID-19, saw increased vaccine demand. Local production and international partnerships in vaccine development are boosting the biotechnology sector. In December 2024, the Public Investment Fund's National Unified Procurement Co. signed an MoU with Shenzhen-based BGI Group to improve healthcare cooperation and deliver comprehensive, high-quality healthcare services. Gene Therapy is an emerging segment driving growth by providing innovative treatments for genetic disorders and life-threatening diseases like cancer.

By Medical Devices (Diagnostic Devices-Leading Share): Diagnostic devices are essential in driving healthcare market growth by enabling early detection and accurate diagnosis of diseases. Imaging systems, blood analyzers, and point-of-care testing tools improve medical care efficiency and precision. With increasing cases of chronic illnesses like diabetes and heart disease, demand for advanced diagnostic tools is growing. Wearable Devices are transforming healthcare by empowering individuals to monitor their health in real-time, tracking vital signs like heart rate, activity levels, and sleep patterns, promoting preventive care and early detection.

By Healthcare IT (Electronic Health Records-Leading Share): Electronic Health Records (EHR) are expected to play a crucial role in healthcare market growth by enhancing efficiency and accuracy of medical data management. EHR systems allow healthcare providers to store, access, and share patient information easily, leading to better care coordination and faster decision-making. As part of Vision 2030, the government is encouraging healthcare digitization, making EHR a key focus. Mobile Health Apps (mHealth) are set to drive growth by providing easy access to health services and information, helping users track fitness, manage chronic conditions, book appointments, and consult doctors remotely.

By Healthcare Infrastructure (Hospital Construction-Leading Share): Hospital construction is expected to expand Saudi Arabia's healthcare market by providing access to high-quality medical services. With a growing population and rising healthcare demands, the government is heavily investing in building advanced hospitals and healthcare facilities as part of Vision 2030. Public-private partnerships are boosting hospital development, ensuring efficient infrastructure expansion. Medical Tourism Facilities are driving growth by attracting international patients looking for high-quality medical care, with world-class infrastructure and skilled professionals positioning Saudi Arabia as a regional hub.

By Healthcare Insurance (Private Insurance-Dominant Share): Private insurance is projected to dominate Saudi Arabia's healthcare market by expanding access to medical services and reducing the financial burden on individuals. With the government promoting privatization in healthcare, private insurance helps cover treatments in private hospitals and clinics, providing faster and more specialized care. It also supports the growing expatriate population, as private insurance is mandatory for non-citizens. Private insurance helps diversify funding sources, reducing pressure on government resources, and aligns with Vision 2030 goals for a sustainable and efficient healthcare system. Preferred Provider Organizations (PPOs) will have significant growth, offering flexible insurance plans that allow patients to choose from large networks of healthcare providers.

By Preventive & Wellness Care (Health and Wellness Programs-Leading Share): Health and wellness programs are set to have a significant share by promoting preventive care and healthier lifestyles. These programs aim to raise awareness about nutrition, physical activity, mental health, and early disease detection, helping to reduce lifestyle-related conditions like obesity, diabetes, and heart disease. Supported by government initiatives under Vision 2030, wellness programs are encouraging individuals to take proactive steps toward improving their health. Fitness Services play a crucial role by promoting healthier lifestyles and preventing lifestyle-related diseases, with gyms, fitness centers, and wellness programs becoming more popular.

🔷 Regional Analysis: Saudi Arabia's Healthcare Transformation Across the Kingdom

Saudi Arabia's healthcare market is experiencing transformation across all regions, driven by Vision 2030 initiatives, population growth, and increasing chronic disease burden.

Major Urban Centers (Riyadh, Jeddah, Dammam): These metropolitan areas concentrate the Kingdom's most advanced medical facilities, including King Faisal Specialist Hospital & Research Centre (KFSH&RC), Saudi German Hospitals Group, and Al Habib Medical Group. These regions attract significant private investment, offer specialized tertiary care, and serve as hubs for medical tourism. The concentration of skilled medical professionals and advanced technology in urban centers drives healthcare innovation and complex procedure availability.

Emerging and Rural Regions: The government is addressing healthcare access gaps in rural areas through telemedicine expansion, mobile health units, and new hospital construction under public-private partnerships. The Ministry of Health's focus on enhancing healthcare access in underserved regions aligns with Vision 2030's goal of equitable healthcare distribution across the Kingdom. The "Regulatory Healthcare Sandbox" program (launched August 2024) provides innovators a secure platform to develop solutions for region-specific healthcare challenges.

Medical Tourism Destinations: The Kingdom is developing specialized medical tourism facilities in strategic locations, offering world-class treatments in cardiology, orthopedics, fertility, and cosmetic surgery. These facilities attract international patients while strengthening domestic healthcare capabilities, contributing to economic diversification goals under Vision 2030.

📄 Get the Full Premium Report Now- https://dimensionmarketresearch.com/checkout/kingdom-of-saudi-arabia-healthcare-market/

🔷 Competitive Landscape: Public Providers, Private Hospital Groups, and International Partners

The healthcare market in Saudi Arabia is highly competitive, with participation from public providers, private hospital groups, pharmaceutical manufacturers, and medical device companies.

Public Healthcare Leaders: King Faisal Specialist Hospital & Research Centre (KFSH&RC) remains a cornerstone of the Kingdom's advanced medical capabilities, conducting cutting-edge research and providing specialized tertiary care. The Ministry of Health oversees the public healthcare system, providing free or subsidized care to citizens.

Private Hospital Groups: Saudi German Hospitals Group, Al Habib Medical Group, NMC Health (NMC Healthcare), and Fakeeh Care Group dominate private healthcare delivery, expanding through new hospital construction, specialized care centers, and strategic partnerships. In October 2024, Fakeeh Care Group announced expansion agreements, and Almoosa Health Group announced new care centers and hospitals as part of the USD 13.3 billion investment package.

Global Medical Technology and Pharmaceutical Leaders: Siemens Healthineers, GE Healthcare, AbbVie, Medtronic, and Novartis maintain strong presence, supplying advanced diagnostic devices, surgical equipment, therapeutics, and pharmaceuticals. These companies benefit from the Kingdom's healthcare infrastructure expansion and focus on advanced medical technologies.

Pharmaceutical and Distribution Partners: Al-Dawaa Pharmacies leads retail pharmaceutical distribution, while NUPCO (National Unified Procurement Company) manages procurement and supply chain. In December 2024, NUPCO signed an MoU with BGI Group to improve healthcare cooperation and leverage advanced expertise for delivering comprehensive healthcare services.

Recent Developments Highlighting Market Momentum:

December 2024: NUPCO signed MoU with BGI Group to improve healthcare cooperation and deliver comprehensive healthcare services.
October 2024: Ministry of Health announced investment deals worth more than USD 13.3 billion, including agreements with NUPCO, Novo Nordisk, Sanofi, Fakeeh Care Group, and Almoosa Health Group.
October 2024: WHO and KSA announced collaboration expanding the Hajj health card initiative to help approximately 3 million pilgrims annually.
August 2024: Ministry of Health launched the "Regulatory Healthcare Sandbox" program to promote advanced solutions reshaping healthcare's future.

🔷 The Road Ahead: What Decision-Makers Need to Know

For B2B decision-makers-healthcare investors, medical device manufacturers, pharmaceutical companies, digital health technology providers, and hospital operators-the strategic imperative is clear: Saudi Arabia's healthcare market is undergoing unprecedented transformation driven by Vision 2030, population growth, and chronic disease burden. The 9.3% CAGR reflects sustained demand across all segments.

Key strategic imperatives include:

Invest in private healthcare delivery and specialized care centers. Private insurance dominance (mandatory for expatriates) and privatization push under Vision 2030 create strong opportunities for private hospital groups and specialized facilities.

Prioritize chronic disease management solutions. Diabetes, cardiovascular conditions, and obesity are major burdens. Providers of specialized care, monitoring systems, and preventive programs will capture significant market share.

Expand digital health and telemedicine capabilities. The Regulatory Healthcare Sandbox program and government support for e-health create opportunities for telemedicine platforms, mHealth apps, AI diagnostic tools, and remote patient monitoring solutions.

Participate in public-private partnerships for infrastructure development. The government is actively seeking private partners for hospital construction, medical tourism facilities, and specialized care centers.

Address the localization imperative. Local manufacturing of pharmaceuticals, biologics, and medical devices is encouraged. Partnerships with local entities (NUPCO, Al-Dawaa) and technology transfer agreements will be advantageous.

The full report from Dimension Market Research provides granular segmentation by healthcare services (hospitals & clinics, ambulatory care, home healthcare, telehealth/telemedicine, long-term care), pharmaceuticals (prescription drugs, OTC, biologics and biosimilars, personalized medicine, orphan drugs), biotechnology (gene therapy, cell therapy, recombinant proteins, vaccines, tissue engineering), medical devices (diagnostic, surgical, therapeutic, wearable, home use, smart devices), healthcare IT (EHR, telemedicine, analytics, mHealth, blockchain, cloud), healthcare infrastructure (hospital construction, medical tourism facilities, specialized care centers, ambulatory care centers), healthcare insurance (private, public, HMO, PPO), preventive & wellness care (wellness programs, nutritional supplements, fitness services, screening and diagnostics), offering actionable intelligence for strategic planning.

📄 Explore the Report with TOC → https://dimensionmarketresearch.com/report/kingdom-of-saudi-arabia-healthcare-market/

For Sales or Inquiries, Contact
Robert John
957 Route 33, Suite 12 #308 Hamilton Square, NJ-08690 USA
Email: enquiry@dimensionmarketresearch.com
United States: (+1 732 369 9777)
Tel No: +91 88267 74855

Dimension Market Research (DMR) is a market research and consulting firm based in India & US, with its headquarters located in the USA. The company believes in providing the best and most valuable data to its customers using the best resources and analysts to work on, to create unmatchable insights into the industries and markets while offering in-depth results of over 30 industries, and all major regions across the world. We also believe that our clients don't always want what they see, so we provide customized reports as well, as per their specific requirements, to create the best possible outcomes for them and enhance their business through our data and insights in every possible way.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Kingdom of Saudi Arabia Healthcare Market to Reach $152.6 Billion by 2034 as Vision 2030 Privatization and Digital Health Transformation Reshape Medical Services here

News-ID: 4511053 • Views:

More Releases from Dimension Market Research

Clinical Trial Supply and Logistics Market to Reach $7.93 Billion by 2034 as Decentralized Trials and Cold Chain Demands Reshape Drug Development Infrastructure
Clinical Trial Supply and Logistics Market to Reach $7.93 Billion by 2034 as Dec …
The global Clinical Trial Supply and Logistics Market is on a robust growth trajectory, with market valuation projected to rise from an estimated USD 4,000.7 million in 2025 to USD 7,926.1 million by 2034, registering a strong compound annual growth rate (CAGR) of 7.9%. According to Dimension Market Research, this expansion is being driven by four converging forces: the escalating number of global clinical trials across pharmaceutical and biotech sectors,
Cellulose Insulation Market to Reach $8.7 Billion by 2034 as Energy-Efficient Building Codes and Sustainable Construction Drive Global Demand
Cellulose Insulation Market to Reach $8.7 Billion by 2034 as Energy-Efficient Bu …
The global Cellulose Insulation Market is on a steady growth trajectory, with market valuation projected to rise from an estimated USD 5.5 billion in 2025 to USD 8.7 billion by 2034, registering a compound annual growth rate (CAGR) of 5.3%. According to Dimension Market Research, this expansion is being driven by three converging forces: stringent energy efficiency regulations and building codes across developed economies, rising consumer demand for sustainable and
Healthy Snacks Market to Reach $212.2 Billion by 2035 as Clean-Label Demand and AI-Powered Formulation Reshape Better-for-You Snacking
Healthy Snacks Market to Reach $212.2 Billion by 2035 as Clean-Label Demand and …
The global Healthy Snacks Market is on a steady growth trajectory, with market valuation projected to rise from an estimated USD 117.9 billion in 2026 to USD 212.2 billion by 2035, registering a compound annual growth rate (CAGR) of 6.8%. According to Dimension Market Research, this expansion is being driven by three converging forces: surging consumer demand for clean-label and functional ingredients, government regulations mandating transparent front-of-pack nutrition labeling, and
Varicose Vein Treatment Market to Reach $3.8 Billion by 2034 as Minimally Invasive Procedures and Aging Population Drive Global Demand
Varicose Vein Treatment Market to Reach $3.8 Billion by 2034 as Minimally Invasi …
The global Varicose Vein Treatment Market is on a steady growth trajectory, with market valuation projected to rise from an estimated USD 2,136.9 million in 2025 to USD 3,813.6 million by 2034, registering a compound annual growth rate (CAGR) of 6.6%. According to Dimension Market Research, this expansion is being driven by three converging forces: the rising global prevalence of varicose veins and chronic venous insufficiency, the rapid adoption of

All 5 Releases


More Releases for Health

Health Coach Market Positioned for Accelerated Growth with Iora Health, Virta He …
Global health coach market is estimated to be valued at USD 18.83 Bn in 2025 and is expected to reach USD 30.65 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2025 to 2032. Latest Report on the Health Coach Market 2025-2032, focuses on a comprehensive analysis of the current and future prospects of the Health Coach Market industry. An in-depth analysis of historical trends, future trends,
Digital Musculoskeletal (MSK) Care Market Top Companies Study - Hinge Health, Sw …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Musculoskeletal (MSK) Care Market Size, Share & Trends Analysis Report Solution (Online/Virtual Consultations, Pain Management Therapy Programs, Remote Monitoring, Others), Condition (Back Pain, Foot & Ankle Pain, Knee & Lower Leg Pain, Neck & Shoulder Pain, Pelvis, Hip & Thigh Pain, Others), End User (Healthcare Providers, Healthcare Payers, Employers, Individuals/Patients, Others)- Market Outlook And
Digital Therapeutics Market Outlook 2025 : Proteus Digital Health, Omada Health, …
ReportsWeb.com has announced the addition of the “Global Digital Therapeutics Market Size, Status and Forecast 2025” The report focuses on major leading players with information such as company profiles, product picture and specification. This report studies the global Digital Therapeutics market, analyzes and researches the Digital Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market,
Digital Therapeutics Market Outlook to 2025 - Propeller Health, CANARY HEALTH, N …
The global digital therapeutics market is segmented on the basis of application, distribution channel, and geography. The application segment includes, respiratory diseases, central nervous system disease, smoking cessation, medication adherence, cardiovascular diseases, musculoskeletal diseases, and other applications. Based on distribution channel, the digital therapeutics market is segmented as, B2B and B2C. Digital therapeutics, a subset of digital health, is a health discipline and treatment option that utilizes a digital and
Digital Therapeutics Market Analysis 2018 | Growth by Top Companies: Proteus Dig …
Global Digital Therapeutics Market to 2025 This report "Digital Therapeutics Market Analysis to 2025" provides an in-depth insight of medical device industry covering all important parameters including development trends, challenges, opportunities, key manufacturers and competitive analysis. Digital therapeutics, a subset of digital health, is a health discipline and treatment option that utilizes a digital and often online health technologies to treat a medical or psychological condition. The treatment relies on behavioral and
Digital Therapeutics Market 2018 Global Key Player Analysis - Omada Health, Twin …
New Intelligence Report on “Digital Therapeutics Market to 2025” is recently published by The Insight Partners. The report aims to provide leading industry players with information such as company profiles, products and services offered, financial information of last 3 yesars, key development in past five years North America is estimated to contribute to the largest share in the digital therapeutics market in the coming years, owing to factors such as, improved